Skip to main content
. 2023 Jul 7;9:230. doi: 10.1038/s41420-023-01513-y

Fig. 1. High TLR3 expression is associated with a better prognosis in pediatric and AYA sarcomas.

Fig. 1

A TLR3 expression is decreased in rhabdomyosarcomas (RMS) compared to their non-tumoral counterpart, i.e. normal skeletal muscles (p-value = 0.0016, unpaired two-sided Wilcoxon test). Publicly available transcriptomic data from Schäfer and Welle’s cohort were downloaded from R2 cancer. B TLR3 expression is associated to a better overall survival probability in pediatric Fusion Positive-RMS samples (p-value = 0.041, log-rank test). Publicly available E-TABM-1202 transcriptomic data were downloaded from ArrayExpress. C TLR3 expression is associated with a better metastasis-free survival probability in a cohort of pediatric and AYA osteosarcomas (p-value = 0.0059, log-rank test). Publicly available transcriptomic data from Kuijjer’s cohort were downloaded from R2 cancer.